Applications for the Postdoctoral Programme is now closed.
About the Programme
The AstraZeneca Post Doc Programme funds post-doctoral projects originating from internal scientists / clinicians across the research areas and scientific disciplines within AstraZeneca’s Innovative Medicine and Early Development (IMED) Biotech Unit. These projects address fundamental scientific challenges that underpin drug discovery and development and are for a two-year period. There is opportunity for a merit based extension. Positions mainly are based on one of our strategic R&D sites in the US (Waltham, Massachusetts), in Sweden (Mölndal), and in the UK (Alderley Park and Cambridge).
Postdoctoral scientists will have the opportunity to conduct independent cutting-edge work in state-of-the-art laboratories while learning and interacting with other AstraZeneca scientists. You will join a vibrant and large Post-Doc community. Each Postdoctoral scientist will also be able to collaborate with a leading academic advisor who will provide further support and guidance. Publication of work in high-quality scientific journals and communication of research findings at international scientific conferences is strongly encouraged. In addition to the availability of specialized drug discovery courses, each post-doctoral scientist receives a tailored training and development programme. These are aligned with the established AstraZeneca approach to personal development as well as key skills, such as presentation delivery and publication writing.
Who can apply
AstraZeneca is seeking talented scientists who are interested in pursuing an academic-style Post Doc in a global pharmaceutical setting and contributing to AstraZeneca’s commitment to delivering innovative medicines and developing the next generation of scientists. We seek motivated, enthusiastic individuals with an excellent track record from a diverse range of scientific disciplines across preclinical to early development including: biochemistry, physiology, cellular and molecular biology, pharmacology, computational biology/chemistry, informatics, medicinal chemistry, biophysics, structural biology, DMPK, safety & toxicology, statistics.
How to join us
The majority of positions are advertised in February of each year. Additional opportunities may become available throughout the year. Please follow AstraZeneca social channels for announcements and you can also register for updates via the connect with us feature and specify post doc as your area of interest.
You will need to complete the online application form that is associated with each of the position. If you are interested in more than one position you will need to fill in an application form for each one. It is important that you take your time to complete your application in full as we place a lot of importance on all areas of the application form.
Short-listed applicants will be invited to a skype-like interview to aid in selection prior to a final assessment centre at one of our core R&D Sites.
Successful candidates will be offered a start date convenient to them and the supervisor but usually within three months of the offer.
Tom, a Senior Research Scientist, who joined AstraZeneca as a Post-Doc in 2010, has gone on to publish five papers on his work and has been able to share his published works with colleagues through internal Post-Doc symposia and poster sessions that are now part of the programme’s annual cycle as well as at International meetings.
“AstraZeneca was the only industry placement I applied for. I opted for it because I wanted to work on science where I could see it have a practical application. Being able to focus on a research project as a Post-Doc gives you the time and space to follow the science where it leads,” – Tom, Sr. Research Scientist and Post Doc participant
His work on synthesising novel, partially saturated bicyclic molecules has been taken up by colleagues who are now building on this knowledge and expertise.
To learn more about our Post-Doc Programme, watch the below ‘Day in the life of a Post-Doc’ video, featuring current postdoctoral researchers from the US, UK and Sweden.
Last reviewed: March 30, 2015